M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

43
M.Verri U.O. Anestesia e Rianimazione Universit Dir.Prof.R.Alvisi

Transcript of M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Page 1: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

M.VerriU.O. Anestesia e Rianimazione UniversitariaDir.Prof.R.Alvisi

Page 2: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Riconoscimento che qualche cosa non va• alterazione del sensorio• dispnea, tachipnea, alterazione della meccanica-dinamica ventilatoria• SpO2

• alterazione della PA• tachicardia, aritmia• contrazione della diuresi• T°• alterazione degli esami ematochimici• ecc.

• quanto sopra +

• iper-ipotermia / leucocitosi-leucopeniainfezione

Quanto non va ? Valutazione della gravità

• giudizio personale• scale di gravità

sepsi, sepsi grave, shock settico

Page 3: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

TachicardiaIpotensione CVP PAOP

Ittero Enzimi Albumina PT

Stato di coscienza alterato, confusione, psicosi

FR > 20 atti/mPaO2 < 70 mm HgSaO2 < 90%PaO2/FiO2 300

Oliguria Anuria Creatinina

Piastrine PT/APTT Proteina C D-dimero

SOFA ?

Page 4: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

3 2 1 0 1 2 3PA sist <70 71-80 81-100 101-199 >200FC <40 41-50 51-100 101-110 111-129 >130FR <9 9-14 15-20 21-29 >=30T °C <35 35-38.4 >=38.5AVPU Alert reagisce reagisce Non reagisce

Voce Pain Unresponsive

Modified Early Warning Score

Modified Early Warning Score

Cut-off >4Subbe CP et al Q J Med 2001; 94: 521-526

3 2 1 0 1 2 3SpO2 % <85 85-89 90-94 >=95Diuresi no <0.5 dialisi 0.5-3 >3 ml/Kg/hPA sist <70 70-79 80-99 100-179 >=180FC <40 40-49 50-99 100-114 115-129 >=130FR <10 10-19 20-29 30-39 >=40T °C <35 35-35.9 36.0-37.4 37.5-38.4 >=38.5GCS Alert Confuso reagisce Non reagisce

voce o solo dolore

Goldhill DR et al Anaesthesia 2005; 60: 547-553

Patient-At-Risk warning scorePatient-At-Risk warning score

Page 5: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Score 1 2 3 4

SNCGCS

13-14 10-12 6-9 <6

RESPIRATORIOPa/FiO2 (mmHg)

< 400 < 300 < 200 con supporto

resp

< 100

CARDIOVASCOLAREIpotensione

MAP < 70 mmHg

Dopa < 5 o DObutamin

a

Dopa > 5 oAdr < 0,1 o

Noradr < 0,1

Dopa > 15Adr > 0,1

Noradr > 0,1

COAGULAZIONEPiastrine(103/mm3)

< 150 <100 <50 <20

FEGATOBilirubina(mg/dl)

1,2-1,9 2,0-5,9 6,0-11,9 >12

RENALECreat (mg/dl) o Diur

1,2-1,9 2,0-3,4 3,5-4,9 o< 500

ml/24h

> 5,0< 200 ml/24 h

Sequential Organ Failure Assessment (SOFA)

Vincent JL, et al. Intensive Care Med 1996;22:707-10

Page 6: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

S.C 37 aa

insuff.respiratoria

cardiopatia

Page 7: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 8: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

• microbiologia• antibioticoterapia• rimozione sorgente

Ottimizzazione perfusione• volemia

• cristalloidi• colloidi• emocomponenti• emoderivati

• tono vascolare• vasocostrittori• vasodilatatori ??

• contrattilità miocardica• dobutamina• (dopamina)

• supporto respiratorio• sostituz.funzione renale• controllo glicemico• nutrizione• sedazione•prevenzione complicanze• ecc.

steroidi ?

Coupled Plasma Filtration AdsorptionCPFA

sono guarito !!!

ECMO

Page 9: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Special admission paths: sepsis R Ferrer, A.Navas, ML Martinez, A.Artigas

• Barochia AV, Cui X, Vitberg D, Suffredini AF, O’Grady NP, Banks SM. Bundled care for septic shock: an analysis of clinical trial. Crit Care Med 2010; 38(2).668-78• Ferrer R, Artigas A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180(9):861-6• Levy MM, Dellinger RP, Bion J. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36(2):222-31

• The key to success involves the implementation of a hospital wide system that recognizes septic patients early, and at the same time rapidly administers effective therapy ( sepsis-rapid response team)(?)

• The results of the meta-analysis are very consistent in showing that sepsis bundles improve survival by improving the way sepsis treatments are delivered

• Health care organizations traditionally favour investing in new technology and drugs, but are reluctant to invest in organizational development. For sepsis care bundles to succeed, this must change

Page 10: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Sepsis is very complex!

Infectious agent?

Pro inflammatorymediator

earlyinhibitors

Receptor activation

Other factors?

Pro- inflammatorymediators

Signal pathway activation

Anti- inflammatorymediators

inhibitors Protein synthesis

Coagulation cascade

Inflammatory cascade

ROS

Da EMC 2010

Page 11: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Immunoinflammatory response of three hypothetical patients with sepsis.

Page 12: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

• microbiologia• antibioticoterapia• rimozione sorgente

Ottimizzazione perfusione• volemia

• cristalloidi• colloidi• emocomponenti• emoderivati

• tono vascolare• vasocostrittori• vasodilatatori ??

• contrattilità miocardica• dobutamina• (dopamina)

• supporto respiratorio• sostituz.funzione renale• controllo glicemico• nutrizione• sedazione•prevenzione complicanze• ecc.

steroidi ?

Coupled Plasma Filtration AdsorptionCPFA

ECMO

Page 13: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 14: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 15: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 16: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 17: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 18: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Cardiac conditions considered to increase a patient’s risk of developing infective endocarditis, i.e. ‘at risk’ heart valve lesions.

Page 19: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

The endocarditis risk in GUCH patients is substantially higher than in the general population, with marked variation between lesions.

It has to be emphasized that good oral hygiene and regular dental review have an essential role in reducing the risk of IE. Aseptic measures are mandatory during manipulation of venous catheters and during any invasive procedure in order to reduce the rate of healthcare-associated IE. GUCH patients should also be discouraged from getting piercings and tattoos.

Page 20: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

The approach to antibiotic endocarditis prophylaxis has changed for several reasons.In short, transient bacteraemia occurs not only after dental procedures but frequently in the context of daily routine activities such as tooth brushing, flossing, or chewing.Due to the lack of scientific evidence for the efficacy of antibiotic prophylaxis, the estimated huge number of patients that may need to be treated to prevent one single case of IE, the small but existing risk of anaphylaxis, and the general problem of emergence of resistant microorganisms resulting from widespread, often inappropriate use of antibiotics, it is currently recommended by expert consensus to limit antibiotic prophylaxis to patients with the highest risk of IE undergoing the highest risk procedures (IIaC).

Page 21: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

This recommendation includes the following patient groups:• Patients with a prosthetic valve or a prosthetic material used for cardiac valve repair• Patients with previous IE• Patients with CHD:

• a cyanotic CHD, without surgical repair, or with residual defects, palliative shunts, or conduits • a CHD after repair with prosthetic material whether placed by surgery or by percutaneous technique, up to 6 months after the procedure (until endothelialization)• a when a residual defect persists at the site of implantation of a prosthetic material or device by cardiac surgery or percutaneous technique.

The recommendation is limited to dental procedures requiring manipulation of the gingival or periapical region of the teeth or perforation of the oral mucosa. Antibiotics are not recommended for respiratory tract, gastrointestinal, genitourinary, dermatological, or musculoskeletal procedures unless there is an established infection.

Page 22: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 23: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 24: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 25: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 26: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 27: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Steroids◦ Consider intravenous hydrocortisone for adult septic shock when

hypotension remains poorly responsive to adequate fluid resuscitation and vasopressors. (2C)

◦ ACTH stimulation test is not recommended to identify the subset of adults with septic shock who should receive hydrocortisone. (2B)

◦ Hydrocortisone is preferred to dexamethasone. (2B)◦ Fludrocortisone (50μg orally once a day) may be included if an

alternative to hydrocortisone is being used which lacks significant mineralocorticoid activity. Fludrocortisone is optional if hydrocortisone is used. (2C)

◦ Steroid therapy may be weaned once vasopressors are no longer required. (2D)

• Hydrocortisone dose should be ≤300 mg/day. (1A)• Do not use corticosteroids to treat sepsis in the absence of shock

unless the patient’s endocrine or corticosteroid history warrants it. (1D)

Page 28: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Steroids

Negli ultimi anni l’uso dei corticosteroidi nello shock settico è risultato controverso

• Pro:– miglioramento emodinamico con più rapida sospensione dei vasopressori– > rapidità di risoluzione della disfunzione d’organo– < mortalità (?)

• Con:– mortalità tra responder e non responder– = rapidità nella sospensione dei vasopressori– > superinfezioni– debolezza neuromuscolare– intolleranza glucidica

Nov.2008

Page 29: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

• Annane D, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-870– Sì steroidi nello shock settico che

richiede vasopressori

• SprungCL, et al. The CORTICUS randomized, double-blind, placebo-controlled study of hydrocortisone therapy in patients with septic shock. N Engl J Med 2008;358:111-124– NO steroidi nello shock settico

Steroids

Page 30: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

SteroidsRecommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine

Crit Care Med 2008; 36:1937–1949

Recommendation 6:Hydrocortisone should be considered in the management strategy of patients with septic shock, particularly those patients who have responded poorly to fluid resuscitation and vasopressor agents.

Strength of Recommendations: 2B

Page 31: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults

Annane D, Bellissant E, Bollaert PE, et al. JAMA. 2009; 301:2362-2375

28-day mortality was modestly reduced (relative risk [RR] = 0.84, P = .05) and was also modestly reduced in the subset of studies reporting prolonged corticosteroid administration (RR = 0.84, P = .02). Treatment increased the proportion of patients achieving reversal of shock and reduced the length of intensive care unit stay without a detectable increase in gastrointestinal bleeding, superinfection, or neuromuscular complications. Corticosteroids did increase the risk for hyperglycemia and hypernatremia. The authors concluded that the prolonged use of corticosteroids safely reduces short-term mortality in patients with severe sepsis or septic shock.

Until a definitive clinical trial answers this question, corticosteroid use will continue to be highly variable and at the discretion of intensivists worldwide

Page 32: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Conclusions: Based on clinically meaningful thresholds (RRR[15–25%) for mortality reduction in severe sepsis or septic shock, the Bayesian approach to all three meta-analyses consistently showed that low-dose steroids were not associated with survival benefits. The probabilities of developing steroid- induced side effects (superinfections, bleeding, and hyperglycemia) were high for all analyses.

Page 33: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

ConclusionPatients randomized to treatment with hydrocortisone demonstrated a faster decrease in total organ dysfunction/failure determined by the SOFA score, primarily driven by a faster improvement in cardiovascular organ dysfunction/failure.This organ dysfunction/failure improvement was not accompanied by a decreased mortality.

R. MorenoC. L. SprungD. AnnaneS. ChevretJ. BriegelD. KehM. SingerY. G. WeissD. PayenB. H. CuthbertsonJ.-L. Vincent

Page 34: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Ideal therapy for sepsis

Plasma

Reinfusate in

UF out

“bad molecules”

“good molecules”

SIRS = Systemic inflammatory response syndrome

CARS = Compensatory anti-inflammatoryresponse syndrome

Hyper-inflammation

Normal

Immunoparalysis

Page 35: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

CPFA used successfully in non-ARF patients

Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock

Marco Formica, Carlo Olivieri, Sergio Livigni, Giulio Cesano, Antonella Vallero, Mariella Maio and Ciro Tetta

Intensive Care Med (2003) 29: 703-708

Objective: The objective was to examine the effect of repeated applications of coupled plasmafiltration-adsorption on the hemodynamic response in septic shock patients hospitalized in intensive care units (ICUs).

Conclusion: Coupled plasmafiltration-adsorption was a feasible and safe extracorporeal treatment and exerted a remarkable improvement in the hemodynamics, the pulmonary function, and the outcome in septic shock patients with or without concomitant ARF.

Page 36: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Anne-Corne´lie J. M. de Pont, MD, PhD Adult Intensive Care Unit Academic Medical Center University of Amsterdam Amsterdam, The Netherlands

…The improvement of blood purification techniques and membranes has generated new opportunities for the use of extracorporeal techniques in sepsis. Removal of both pro- and anti-inflammatory mediators by means of these new techniques is feasible and might add to the restoration of homeostasis by controlling excessive cytokine production (the so-called peak concentration hypothesis). Whether this approach will result in a better clinical outcome for patients with severe sepsis remains to be investigated.

Page 37: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 38: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 39: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 40: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.
Page 41: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

• microbiologia• antibioticoterapia• rimozione sorgente

Ottimizzazione perfusione• volemia

• cristalloidi• colloidi• emocomponenti• emoderivati

• tono vascolare• vasocostrittori

• contrattilità miocardica• dobutamina

• supporto respiratorio• sostituz.funzione renale• controllo glicemico• nutrizione• sedazione•prevenzione complicanze• ecc.

steroidi ?

proteina C attivataricombinante ?(Drotrecogin)

sono guarito !!!

Page 42: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Da Intensive Care Med 2010;36(12): 2019-2029

Page 43: M.Verri U.O. Anestesia e Rianimazione Universitaria Dir.Prof.R.Alvisi.

Indications for echocardiography in suspected infective endocarditis. IE, infective endocarditis; TTE, transthoracic echocardiography; TOE, transoesophageal echocardiography. TOE is not mandatory in isolated right-sided native valve IE with good quality TTE examination and unequivocal echocardiographic findings.